Antibiotics for exacerbations of chronic obstructive pulmonary disease
35 results
1 - 35
Improved outcomes with azithromycin vs beta-lactams for acute exacerbations of chronic obstructive pulmonary disease- Antibiotic and corticosteroid treatment effective for acute exacerbations of COPD
- Corticosteroids, selective use of antibiotics and NPPV for COPD exacerbations
- For mild to severe COPD exacerbations, antibiotics and steroids remain the mainstay of treatment
- Short-course antibiotics effective for acute exacerbation of COPD
- C-reactive protein helps reduce antibiotic prescribing for COPD exacerbations
- Sputum purulence and CRP predict poor prognosis with COPD exacerbation
- Procalcitonin test can reduce antibiotic use in COPD
- C-reactive protein guidance safely reduces antibiotic use in patients with acute exacerbation of COPD (NNT = 5)
- In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
- Amox-clavulanate during COPD exacerbations decreases Sx and delays subsequent exacerbations
- One year of once-daily doxycycline does not reduce exacerbation frequency in adults with moderate to severe COPD
- Providing procalcitonin levels does not reduce antibiotic use in patients with lower respiratory tract infections
- Procalcitonin reduces antibiotic prescribing for acute bronchitis but not other causes of lower respiratory tract infection
- Short-term antibiotic treatment is suitable for several outpatient infections
- More evidence against antibiotics for acute asthma exacerbations
- Procalcitonin testing decreases antibiotic use
- Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease
- Mepolizumab provides only a small reduction in moderate exacerbations when added to triple inhaler therapy for eosinophilic COPD (MATINEE)
- Triple inhaled therapy provides a small reduction in moderate exacerbations, no effect on severe exacerbations (ETHOS)
- Fewer exacerbations but somewhat more pneumonia with triple inhaler therapy for COPD (IMPACT)
- Delayed Rx for respiratory infections produces similar results and satisfaction as immediate treatment